Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
136 JPY | 0.00% | -3.55% | +1.49% |
Business Summary
Number of employees: 38
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio - Successor
92.7
%
| 1,543 | 98.3 % | 2,573 | 92.7 % | +66.72% |
Cellular Therapy
7.3
%
| 26 | 1.7 % | 204 | 7.3 % | +678.95% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 1,569 | 100.0 % | 2,776 | 100.0 % | +76.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yasuo Sakae
ADM | Chief Administrative Officer | - | - |
Director/Board Member | - | - | |
Osamu Sugawara
AUD | Comptroller/Controller/Auditor | 65 | 18-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norikazu Eiki
BRD | Director/Board Member | 76 | 18-05-31 |
Director/Board Member | - | - | |
Aya Chiba
BRD | Director/Board Member | 38 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 38,939,913 | 24,813,124 ( 63.72 %) | 93 ( 0.000239 %) | 63.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KIDSWELL BIO CORPORATION 0.00% | 93 | 0.00% | 92 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.49% | 33.64M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4584 Stock
- Company Kidswell Bio Corporation